← Back to Search

Procedure

TriLift for Dry Eye and Eyelid Laxity

Verified Trial
N/A
Waitlist Available
Led By James G Chelnis, MD
Research Sponsored by Lumenis Be Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Could you come to Manhattan for 5 visits over 2 months?
Are you 22 years old or older?
Timeline
Screening 1 day
Treatment 1 months
Follow Up 1 months
Awards & highlights
No Placebo-Only Group

Summary

This trial showed that a combo of drugs & RF can help improve dry eye symptoms.

Who is the study for?
This trial is for adults over the age of 22 who experience eye irritation or dryness and can travel to Manhattan for five visits across two months. Specific details on exclusion criteria are not provided.
What is being tested?
The study is testing the TriLift device, which uses Dynamic Muscle Stimulation (DMSt) + Radiofrequency (RF) to potentially improve the quality of blinking in people with dry eye disease.
What are the potential side effects?
Potential side effects are not detailed in the information provided, but may typically include discomfort at the treatment site, mild swelling or redness, and temporary muscle twitching.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 1 day
Treatment ~ 1 months
Follow Up ~1 months
This trial's timeline: 1 day for screening, 1 months for treatment, and 1 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Impaired blink quality
Other study objectives
Adverse events
BCVA
Blink rate
+9 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: TriLiftExperimental Treatment1 Intervention
Combination of Dynamic Muscle Stimulation and Radiofrequency

Find a Location

Logistics

Other reimbursement is provided

Other forms of reimbursement are provided for this trial.

Who is running the clinical trial?

Lumenis Be Ltd.Lead Sponsor
37 Previous Clinical Trials
1,383 Total Patients Enrolled
James G Chelnis, MDPrincipal InvestigatorManhattan Face and Eye

Media Library

TriLift device (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05945069 — N/A
Dry Eye Syndrome Research Study Groups: TriLift
Dry Eye Syndrome Clinical Trial 2023: TriLift device Highlights & Side Effects. Trial Name: NCT05945069 — N/A
TriLift device (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05945069 — N/A
Dry Eye Syndrome Patient Testimony for trial: Trial Name: NCT05945069 — N/A
~13 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top